People

Palamar-276-303
Joseph Palamar, PhD, MPH
NYU Langone Health - Associate Professor, Department of Population Health
Education
PhD, Public Health, New York University
MPH, Public Health, New York University
MA, Educational Psychology, New York University
BA, Forensic Psychology, John Jay College of Criminal Justice
Research Interests
Epidemiology of illicit drug use, Club drugs, New psychoactive substances, Stigma, Risky sexual intercourse
BIO
Joseph Palamar’s research and publication record reflect his commitment to investigate the epidemiology of drug use. He has a diverse background in psychology, epidemiology, and in the study of drug use, and specializes in psychosocial correlates of drug use. He has focused heavily on the epidemiology of new psychoactive substance use, “club drug” use, and drug-related risky sexual behavior — especially within the electronic dance music (EDM) nightclub and festival scene. He also has extensive experience analyzing data from large national datasets such as Monitoring the Future and the National Survey on Drug Use and Health.
Projects
Principal Investigator, New Psychoactive Substance Exposure among NYC Nightclub and Festival Attendees. Active
Principal Investigator, Development of a Rapid Survey to Detect Use of New and Emerging Drugs. Completed
Principal Investigator, Drug Use Among Nightclub and Dance Festival Attendees in New York City. Completed
Principal Investigator, Pilot Study Examining the Sexual Effects of Cannabis Use. Completed
Principal Investigator, Pilot Study to Collect Saliva and Follow-up Survey Response Rates among EDM Party Attendees. Completed
Principal Investigator, Use of Psychoactive Drugs and Sexual Risk Behavior among Nightclub and Festival Attendees. Completed
Publications

Recent

Palamar JJ, Fitzgerald ND, Carr TH, Rutherford C, Keyes KM, Cottler LB (2024).
National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017-2022
Drug and Alcohol Dependence [Epub 2024 Feb 6] . doi: 10.1016/j.drugalcdep.2024.111086.

Palamar JJ (2024).
Drug checking for fentanyl as surveillance to inform monitoring of overdose risk
American Journal of Preventive Medicine, 66 (2), 384-385. doi: 10.1016/j.amepre.2023.09.030.

Palamar JJ, Massano M, Salomone A (2024).
Five cases of unintentional exposure to BZO-4en-POXIZID among nightclub attendees in New York City
Journal of Analytical Toxicology, 48 (1), 75-80. doi: 10.1093/jat/bkad086.

Wilkinson ST, Palamar JJ, Sanacora G (2024).
The rapidly shifting ketamine landscape in the US
JAMA Psychiatry [Epub 2024 Jan 3]. doi: 10.1001/jamapsychiatry.2023.4945.

Yang KH, Tam RM, Satybaldiyeva N, Kepner W, Han BH, Moore AA, Palamar JJ (2023).
Trends in past-month cannabis use among US adults across a range of disabilities and health conditions, 2015-2019
Preventive Medicine, 177, 107768. doi: 10.1016/j.ypmed.2023.107768.

Dr. Palamar's MyBibliography Profile
Selected Press